Doyle Johnson

Doyle has more than 30 years of experience in the pharmaceutical industry, working for operating companies as well as Architecture and Engineering companies.

He has been an individual contributor as well as a leader of departments and projects for everything from Validation Master Plans to the design of $125 million Monoclonal Antibody Facilities.  He was the Senior Director of Facilities, Engineering and EHS at Genzyme’s Framingham site during the FDA Consent Decree and has also served as the President of the ISPE Boston Area Chapter and been a member of the ISPE International Board of Directors.  He is most familiar with the design and operation of facilities, equipment, and biological processes, having presented on those topics at international meetings of ISPE.  He has also worked in R&D and process development labs and pilot plants, developing a keen awareness of not just the chemistry and scaleup issues but also the financial considerations of successful production processes.   He has performed audits of production facilities for compliance with GMP.